IRIS
BARSOTTI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.564
Totale 8.564
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 8.564
Totale 8.564
Salva come PNG Salva come JPEG
Città #
Genova 6.503
Rapallo 1.228
Genoa 802
Bordighera 30
Vado Ligure 1
Totale 8.564
Salva come PNG Salva come JPEG
Nome #
Acute coronary syndromes do not promote prolonged in vivo FXII-dependent prothrombotic activity 159
Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy. 149
Sublethal Doses of an Anti-erbB2 Antibody Leads to Death by Apoptosis in Cardiomyocytes Sensitized by Low Prosenescent Doses of Epirubicin: The Protective Role of Dexrazoxane. 148
ACE inhibitors can induce circulating antibodies directed to antigens of the superficial epidermal cells. 137
C242T polymorphism in CYBA gene (p22phox) and risk of coronary artery disease in a population of Caucasian Italians 133
Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2 130
Carvedilol Prevents Doxorubicin-induced Free Radical release and Oxidative Damage in Cardiomyocytes. 126
Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts. 123
Increased neutrophil lifespan in patients with congestive heart failure. 123
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis 122
Blunted coronary flow reserve in systemic sclerosis: a sign of cardiac involvement in asymptomatic patients 122
CYBA polymorphism associated with oxidative stress in Italian patients with early onset of coronary artery disease. 120
ALTERED CELL-FUNCTION ASSOCIATED TO LOSS OF CELL-MATRIX ADHESION: PRELIMINARY DATA ON A RAT AORTIC SMOOTH MUSCLE CELL LINE 119
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. 118
Protective effects of carvedilol against doxorubicin-induced apoptosis in cardiac muscle cells 115
Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy. 114
Maximal endothelial tissue plasminogen activator release is not impaired in patients with acute coronary syndromes before heparin treatment. 113
High doses of atorvastatin do not affect activity of prothrombinase in patients with acute coronary syndromes 111
MR EVALUATION OF CORONARY STENTS WITH NAVIGATOR ECHO AND BREATH-HOLD CINE GRADIENT-ECHO TECHNIQUES 108
Hypoadiponectinemia in lipodystrophic HIV individuals: a metabolic marker of subclinical cardiac damage 108
Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure. 107
SOLUBLE FORM OF THE ENDOTHELIAL ADHESION MOLECULECD146 BINDS PREFERENTIALLY PROINFLAMMATORYPROATHEROSCLEROTICCD16+ MONOCYTE SUBSET 107
Acute myocardial infarction related to very late sirolimus-eluting stent thrombosis 6 months after discontinuation of dual antiplatelet therapy 106
Brachial Artery Endothelial-dependent Flow-mediated Dilation Identifies Early-stage Endothelial Dysfunction in Systemic Sclerosis and Correlates with Nailfold Microvascular Impairment 105
Cyba polymorphism associated to oxidative stress in italian patients with early onset coronary artery disease. 4th meeting of the ETRO working party on population genetics of haemostatic risk factors for arterial vascular disease 102
OxLDL- and HSP-60 antigen-specific CD8(+) T lymphocytes are detectable in the peripheral blood of patients suffering from coronary artery disease. 102
Carvedilol prevents mitochondrial membrane potential loss induced by doxorubicin in cardiomyocytes 101
Systemic levels of oxidative stress and title of autoantibodies in patients with ischemic heart disease at their first clinical manifestation. 99
Matrix metalloproteinase-2 and-9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase 98
Soluble form of the endothelial adhesion molecule CD146 binds preferentially CD16+ monocytes. 96
Plasmatic Levels of metalloproteinases 2 and 9 are increased in patients with congestive heart failure. 94
Attivazione del fattore coagulativo XII in pz con angina stabile ed instabile 94
Postprandial serum induces apoptosis in endothelial cells: role of plymorphonuclear-derived myeloperoxidase and metalloproteinase-9 activity 93
Intense lipid peroxidation in premature clinical coronary atherosclerosis is associated with metabolic abnormalities 91
Early Age of onset of unstable angina is associated to major oxidative stress 91
Associazione tra lipoperossidazione ed insorgenza giovanile di aterosclerosi coronarica. 89
Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events. 89
PROGENITOR CD34+ CELLS AND CIRCULATING ENDOTHELIAL CELLS IN PATIENTS WITH ACUTE OR CHRONIC HEART FAILURE 88
Biliopancreatic diversion reduces QT interval and dispersion in morbidly obese patients 88
N-acetyl-cysteine Regulates the Response to Injury in NZW Rabbit Aorta. 88
Plasma Levels of matrix metalloproteinase-9 and matrix metalloproteinase-2 are increased in plasma of patients with heart failure 87
Controllo antagonista di p38 e JNK nella regolazione della senescenza e di p16INK4A indotte dalla doxorubicina nei progenitori delle cellule endoteliali 87
Comparison between the potential protective mechanisms of carvedilol and atenolol against doxorubicin induced cardiac muscle cell damage and death in vitro. 86
Cor triatratum sinistrum and persistent left superior vena cava: an original association. 86
Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with naifold microvascular impairment 86
Improved assessment of left ventricular volumes and ejection fraction by contrast enhanced harmonic color Doppler echocardiography 86
LA DOXORUBICINA ALTERA L’ESPRESSIONE DELL’IGF-1R E DELL’IGFBP3 IN CELLULE MUSCOLARI CARDIACHE. UN NUOVO MECCANISMO DI CARDIOTOSSICITÀ 85
Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis 83
BASSE DOSI DI DOXORUBICINA PORTANO I CARDIOMIOCITI A MORTE TARDIVA PER CATASTROFE MITOTICA DOVUTA AD UNA ALTERATA REGOLAZIONE DELLE PROTEINE DEL TELOMERO: RUOLO DELLE MAPKs E DI p53 82
Confronto fra meccanismi potenzialmente protettivi di carvedilolo e atenololo contro il danno e la morte di cellule muscolari cardiache indotti dalla doxorubicina in vitro. 80
UN PASTO IPERLIPIDICO INDUCE STRESS OSSIDATIVO DERIVATODALL’ATTIVITÀ DELLA MIELOPEROSSIDASI E DETERMINA L’AUMENTO DELL’ATTIVITÀ DELLE METALLOPROTEASI 80
Elevated plasma levels of lipid peroxidation are associated to an early onset of UA 79
Doxorubicin promotes metalloproteinases-2 trancriptional and zymographic activity in cardiac muscle cells via Nadph oxidase-derived reactive oxygen species. 78
Osteopontin plasma levels correlate with coronary atherosclerosis extension and in-stent restenosis in coronary artery disease patients undergoing percutaneous coronary intervention 77
Coronary aneurysms and stenosis detected with magnetic resonance coronary angiography in a patient with Kawasaki disease. 76
Reduction of cardiovascular morbidity and mortality in type 2 diabetes. A rational approach to hypoglycemic therapy 76
Transcatheter occlusion of PFO and ASD in cryptogenic stroke 74
Autoanticorpi contro proteine ossidate in pazienti con recente sviluppo di angina instabile. 73
Accuracy of noninvasive monitoring of coronary flow velocity reserve with transthoracic echo-doppler in detecting coronary restenosis after successfull coronary angioplasty: a multicenter study 71
Oxidative stress, apoptosis and immunological activation in acute myocardial infarction 71
ALTERAZIONI DELLE PROTEINE TELOMERICHE E SENESCENZA: UN NUOVO MECCANISMO DI CARDIOTOSSICITÀ DA ANTRACICLINE 71
Thrombus determinants of vascular cell activation. 71
La doxorubicina induce nei cardiomiociti la metalloproteasi di tipo 2 attraverso le specie reattive dell’ossigeno prodotte dalla NADPH ossidasi. 70
A PATHOGENETIC HYPOTHESIS ABOUT ELECTRIC STORM. 69
Early age of onset of unstable angina is associated with major oxidative stress 68
Markers of oxidative stress evaluated in patients with ischemic heart disease at the time of their first clinical manifestation. 68
Relazione tra Stress Parietale e Risposta Infiammatoria Sistemica con Danno Miocardico in pazienti con Insufficienza Cardiaca Cronica in fase Stabile 68
Doxorubicin induces activation of Metalloproteinase-2 and –9 in cardiomyocytes through the MAPKinase pathways: protective effects of carvedilol and dexrazoxane 68
Time-course of acute myocardial infarction-dependent peripheral mobilisation of endothelial progenitor cells 68
Traditional risk factors for ATS do not explain major oxidative stress levels in patients with early age onset of unstable angina: possibile role for genetic factors? Population genetics of haemostatic risk factors for arterial vascular disease. 66
Il carvedilolo protegge le cellule endoteliali contro la produzione di radicali liberi e l’apoptosi indotte da doxorubicina. 64
STRESS OSSIDATIVO E P53 MEDIANO L’INIBIZIONE DI IGF-1R INDOTTA DA DOXORUBICINA IN CELLULE MUSCOLARI CARDIACHE 63
Myocardial magnetic resonance spectroscopy 63
Prevalence of persistent left superior vena cava and its implication in pacemaker implantation 62
Il carvedilolo previene la formazione di radicali liberi e il danno ossidativo indotto da doxorubicina sui cardiomiociti. 62
Insorgenza precoce di angina instabile e livelli plasmatici di perossidazione lipidica 61
Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI: a prospective clinical study 61
Un pasto iperlipidico rende il siero pro-apoptotico per le cellule endoteliali: ruolo dell’infiammazione e stress ossidativo. 60
La doxorubicina induce apoptosi e senescenza nei progenitori delle cellule endoteliali e regola l'azione chemiotattica dei cardiomiociti nei loro confronti 60
Up-regulation of lectin-like oxidised LDL receptor-1 (LOX-1) in cardiac muscle cells and implications in doxorubicin-induced cardiotoxicity. 60
Evaluation of Xa/Va activity bound to platelet-rich thrombi in patients with acute coronary syndromes 60
IL SIERO POSTPRANDIALE MOSTRA EFFETTI PRO-OSSIDANTI E PROAPOPTOTICI SULLE CELLULE ENDOTELIALI 58
Elevata attivita’ di metalloprteasi 2 e 9 circolanti nei pazienti con scompenso cardiaco 58
Doxorubicin induces LOX-1 expression in cardiac myocytes via oxidative stress: role of cardioprotective agents 57
Neutrophil-derived matrix metalloproteinase 9 is increased in patients with heart failure 57
TRATTAMENTI SEQUENZIALI CON DOSI SUB-APOPTOTICHE DI EPIDOXORUBICINA ED ANTICORPO ANTI erbB2 INDUCONO APOPTOSI NEI CARDIOMIOCITI: RUOLO CARDIOPROTETTIVO DEL DEXRAZOXANE. 56
Dispersione del QT in Soggetti con Insufficienza Renale Cronica Trattati con Dialisi Peritoneale o con Emodialisi. 56
La doxorubicina induce le metalloproteasi 2 e –9 attraverso l’attivazione delle MAPK: ruolo protettivo del carvedilolo e del dexrazoxane., 56
Meccanismi di tossicità indotta da doxorubicina su cardiomiociti e razionale per l’uso dei farmaci protettivi nella pervenzione del danno cardiaco 56
Il carvedilolo previene la perdita del potenziale di membrana mitocondriale indotta da doxorubicina nei cardiomiociti 55
Pazienti con manifestazione precoce di angina instabile non presentano correlazioni tra livelli di stress ossidativo e autoanticorpi diretti contro proteine ossidate. 55
Ruolo del Polimorfismo C242T della Subunità p22phox del Complesso NAD(P)H Ossidasi in Pazienti con Aterosclerosi Coronarica. 55
Involvement of neutrophils and of C-C chemokines in chronic heart failure 50
Mobilizzazione ematica di sottopopolazioni di progenitori di cellule endoteliali in pazienti con infarto acuto del miocardio 49
Polimorfismo nel gene cyba: possibile marcatore di suscettibilita’ genetica all’aterosclerosi 48
La doxorubicina induce l’aumento della trascrizione e dell’attività della MMP-2 nelle cellule muscolari cardiache attraverso le specie reattive dell’ossigeno prodotte dalla NADPH ossidasi. 47
La doxorubicina induce l’espressione di LOX-1R in cellule muscolari cardiache attraverso un incremento dello stress ossidativo: ruolo di molecole cardioprotettive 46
SUBSET MONOCITARI CD14 CD16 IN PAZIENTI CON SCOMPENSO CARDIACO CONGESTIZIO. 46
Primary percutaneous transluminal angioplasty in the setting of multivessel disease 43
Effetto protettivo del carvedilolo contro la morte per apoptosi indotta da doxorubicina in cellule muscolari cardiache. 43
Totale 8.383
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.151
article - articoli 18.381
book - libri 0
conference - conferenze 3.770
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.302
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.071 53 45 117 94 187 206 298 87 160 456 264 104
2020/2021335 24 33 17 26 13 36 6 30 49 31 32 38
2021/20221.205 9 102 84 159 68 65 76 308 23 121 45 145
2022/20231.430 130 78 6 161 280 239 6 106 231 5 165 23
2023/2024598 23 83 10 54 52 129 37 37 59 7 32 75
2024/202533 33 0 0 0 0 0 0 0 0 0 0 0
Totale 8.577